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According to South Africa (SA)’s most recent cancer 
registry, breast cancer is the leading cancer among 
SA women, with a lifetime risk of 1 in 34.[1] SA is 
a country with citizens of diverse ethnicity: black 
African (80.2%), white Caucasian (8.5%), mixed/
coloured (8.9%) and Indian/Asian (2.4%).[2] The lifetime risk of 
breast cancer differs according to ethnicity: 1/52 in black women, 
1/22 in coloured women, 1/19 in Indian women and 1/18 in white 
women.[1] While the incidence is lowest among black women, it is 
rising as a result of increased life expectancy and urbanisation, which 
leads to lifestyle changes that elevate exposure to known risk factors 
for breast cancer such as dietary changes, decreased exercise, delayed 
and decreased parity, and reduction in breastfeeding.[3] Although 
there is a lower incidence of breast cancer in SA in comparison with 
developed countries, the mortality rate of existing breast cancer 
patients is higher owing to limited access to diagnostic centres, 
particularly in rural areas, lack of awareness, low standards of 
healthcare facilities and limited screening.[4]
Familial breast cancer caused by mutations in high-penetrance genes 
such as BRCA 1 and BRCA 2 accounts for only 5% of all breast cancers. 
The majority of breast cancers are sporadic and are due to mutations in 
a number of low-penetrance genes. Candidate genes for breast cancer 
risk include those involved in DNA damage repair pathways. Mutations 
in genes regulating these pathways are characterised by increased 
chromosomal radiosensitivity.[5] Measurement of chromosomal 
radiosensitivity has been used as an indirect measure of cancer 
susceptibility. The association between chromosomal radiosensitivity 
and cancer risk is supported by the following facts: cancer-prone 
disorders such as ataxia telangiectasia present with high chromosomal 
radiosensitivity; elevated chromosomal radiosensitivity is an indicator 
of defects in DNA repair that could lead to the chromosomal 
instability often observed in cancer; and chromosomal radiosensitivity 
is linked with early events in carcinogenesis.[6]
Several studies (reviewed in Cardinale et al.[7]) on European, Asian 
and American populations have shown breast cancer patients to 
have elevated chromosomal radiosensitivity compared with healthy 
individuals. Studies on the chromosomal radiosensitivity of breast 
cancer patients have never been performed in SA.
Chromosomal radiosensitivity can be measured using the 
cytokinesis-block micronucleus assay. Micronuclei (MN) are 
small nuclei that form in the cytoplasm when chromosomes or 
chromosome fragments are not incorporated into the daughter nuclei 
subsequent to cell division. MN can contain whole chromosomes 
(mis-segregated during mitosis) or acentric fragments, which are 
usually the result of misrepaired or unrepaired DNA double-strand 
breaks. MN are counted in cells that have undergone a single division; 
however, cytokinesis is blocked by adding cytochalasin B, which 
results in binucleated (BN) cells. This assay is well established, robust 
and can be performed on lymphocytes, which are easily obtained 
through venepuncture. The automation of MN scoring with the 
Metafer 4 platform (MetaSystems, Germany) has minimised the 
variability of the assay and rendered it rapid and less subjective.
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Objective
To measure the chromosomal radiosensitivity 
of SA breast cancer patients in a case-control 
study design with the micronucleus assay and 
the Metafer 4 scoring system. Recent studies 
have shown how tumour characteristics of 
breast cancer can differ among different ethnic 
groups.[8,9] The differences between the ethnic 
groups point to differences in the underlying 
biology of the disease and led to the idea 
of comparing chromosomal radiosensitivity 
in different ethnic groups. We also assessed 
whether there was an influence of clinical 
parameters on chromosomal radiosensitivity.
Materials and methods
Subjects
Blood samples were collected from 68 breast 
cancer patients (mean age (standard deviation 
(SD)) 52 (12)) recruited from Charlotte 
Maxeke Johannesburg Academic Hospital 
(CMJAH), a public hospital in Johannesburg, 
Gauteng Province, South Africa, and Donald 
Gordon Medical Centre, a private hospital in 
Johannesburg. We included 30 black breast 
cancer patients (mean age 47 (12) years), 25 
white breast cancer patients (mean age 59 
(11) years), 7 Indian breast cancer patients 
(mean age 45 (8) years) and 6 coloured breast 
cancer patients (mean age 49 (8) years). 
Exclusion criteria included prior chemo- and/
or radiotherapy. Clinical and biographical 
information on the patients was obtained 
through questionnaires and hospital files. 
All patients were categorised by race (black, 
white, Indian, coloured) based on patients’ self-
reported data from the questionnaires. Most 
of the breast cancer patients (80.0%) had inva-
sive ductal carcinomas, of which 31.1% were 
stage 0 - I, 53.3% stage II and 15.6% stage 
III. Overall 74.1% were oestrogen receptor 
(ER)-positive, 63.8% were progesterone 
receptor (PG)-positive and 78.6% were human 
epidermal growth factor receptor 2 (HER2)-
negative. No participant was HIV-positive.
Blood samples from 70 healthy controls 
(mean age (SD) 35 (12) years), including 20 
black women (mean age 36 (15) years), 35 
white women (mean age 36 (10) years), 8 
Indian women (mean age 32 (6) years) and 
7 coloured women (mean age 31 (13) years), 
were also collected. The healthy donors were 
staff members and students from CMJAH, 
where the study was undertaken. All donors 
signed informed consent. Ethical approval for 
the study was obtained through the Human 
Research Ethics Committee, University of the 
Witwatersrand, Johannesburg (M110248).
Irradiations and micronucleus assay
The protocol for the micronucleus assay 
described by Herd et al.[10] was used in this 
study. In brief, 0.5 mL of heparinised blood 
was added to 4.5 mL of RPMI 1640 (Bio-
Whittaker, USA) supplemented with 13% 
fetal bovine serum (Gibco-Invitrogen, USA), 
and antibiotics (50 U/mL penicillin and 
50 mg/mL streptomycin; Gibco-Invitrogen, 
USA). The medium was pre-warmed to 37°C 
and gassed (5% CO2/95% air). Culture flasks 
with blood and medium were irradiated 
with doses of 2 Gy or 4 Gy of X-rays using 
a 6 MV photon beam from a medical linear 
accelerator (Siemens Healthcare, Germany). 
A 0 Gy dose was used as a sham-irradiated 
control. For each dose point, two cultures 
were set up. Immediately after irradiation the 
lymphocytes were stimulated with 100  µL 
phytohaemagglutinin (stock solution 1 mg/
mL; Sigma-Aldrich, USA), and 23 hours 
later 20 µL cytochalasin B (stock solution 
of 1.5 mg/mL; Sigma-Aldrich) was added 
to block cytokinesis. Cells were harvested 
at 70 hours after stimulation using a cold 
(4°C) hypotonic shock with 7 mL 0.075M 
KCl (Merck, Germany). This was followed 
by fixation in methanol:acetic acid:Ringer 
(0.9% NaCl) solution (4:1:5) (Merck). 
Fixed cell suspensions were dropped on 
coded slides and stored at 4°C. Slides were 
mounted with Vectashield containing DAPI 
(4,6-diamidino-2-phenylindole; Vector Lab-
oratories, USA) before being scanned auto-
matically with the Metafer 4 system. The 
classifier and scoring method was based on 
Herd et al.[10] Each dose point was scored 
by at least two scorers. All results were 
normalised to an MN frequency in 1 000 BN 
Table 1. Spontaneous and radiation-induced MN values in breast cancer patients and 
healthy controls, according to ethnicity
Group Patients Controls p-values
Black  
n 30 20
MN/1 000 BN cells, mean (SD)
0 Gy 14 (8)* 10 (4) 0.0087
2 Gy 179 (30)* 159 (31) 0.0273
4 Gy 498 (91)* 449 (66) 0.0324
White  
n 25 35
MN/1 000 BN cells, mean (SD)
0 Gy 16 (7)* 11 (4) 0.0083
2 Gy 172 (24)* 158 (23) 0.0253
4 Gy 507 (79)* 443 (35) 0.0006
Coloured
n 6 7
MN/1 000 BN cells, mean (SD)
0 Gy 12 (9) 12 (7) 0.6043
2 Gy 193 (49) 169 (20) 0.4697
4 Gy 487 (103) 444 (51) 0.5281
Indian
n 7 8
MN/1 000 BN cells, mean (SD)
0 Gy 11 (6) 11 (5) 0.8427
2 Gy 172 (28) 177 (34) 0.8000
4 Gy 467 (91) 470 (74) 0.9305
All groups
n 68 70
MN/1 000 BN cells, mean (SD)
0 Gy 14 (7)* 11 (5) 0.0012
2 Gy 177 (30)* 161 (27) 0.0014
4 Gy 497 (86)* 448 (52) 0.0001
*Significantly different from controls.
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cells. Radiation-induced MN values were 
obtained by subtracting baseline (0 Gy dose) 
values from those obtained in irradiated 
samples.
Statistical analysis was performed with 
Graphpad Prism 6. Differences between 
means of MN yields of patients and controls 
in black and white populations were tested 
for significance with the unpaired Student’s 
t-test. For comparison of differences in MN 
values in the Indian and coloured subgroups, 
and between ER receptor subgroups, the 
Mann-Whitney U-test was applied. This test 
is used for small sample sizes. To analyse the 
correlations between age, clinical parameters 
and MN values, we used Pearson’s 
correlation coefficient. The confidence level 
of the statistical tests was 95%, and statistical 
significance was set at p<0.05.
Results
The results obtained with the micronucleus 
assay on the samples of 68 breast cancer 
patients and 70 healthy individuals are 
presented in Table 1. The mean spontaneous 
MN yields of all the breast cancer patients 
were significantly higher than those of the 
healthy controls (p<0.005). The spontaneous 
MN yields were significantly correlated 
with the age of the healthy individuals, but 
this correlation could not be observed in 
the breast cancer patient group (p<0.005). 
To investigate whether ethnicity had an 
influence on chromosomal radiosensitivity, 
we split the breast cancer patients and 
the healthy controls into four subgroups 
(black, white, coloured and Indian). When 
the patients and controls were grouped 
according to their ethnicity, the significantly 
higher number of spontaneous MN was 
only seen in the black and white patients 
compared with the healthy individuals of the 
same ethnicity.
The radiation-induced MN yield was 
calculated by subtracting the spontaneous 
yield from the yield in the irradiated 
cells. For the whole group of breast 
cancer patients, the mean MN yields were 
significantly higher than in the whole 
group of healthy individuals for both 2 
Gy and 4 Gy irradiations. Grouping the 
samples according to their ethnicity revealed 
significantly higher radiation-induced MN 
values in the black and white breast cancer 
patients for both 2 Gy and 4 Gy. This 
could not be observed in the coloured and 
Indian subgroups (Table 1). Histograms of 
radiation-induced MN after 4 Gy for the four 
ethnic subgroups are presented in Fig. 1. The 
MN distribution after 2 Gy showed similar 
patterns for the four subgroups (data not 
shown). Although no significant differences 
in mean MN values could be seen in the 
coloured group, there was a shift of values 
towards the higher range. This shift was not 
noted in the Indian population.
All the breast cancer patients were also 
split into groups according to clinical 
parameters, and MN values in these groups 
were compared. No significant correlation 
could be found between clinical parameters 
(tumour histological type, size and staging) 
and MN yields of the breast cancer patients. 
There was an effect of ER positivity on the MN 
yields (Fig. 2). Breast cancers positive for ER 
receptors had significantly higher radiation-
induced MN values than ER-negative breast 
cancers for both 2 Gy and 4 Gy (ER-positive 
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Fig. 1. Distribution of MN yields after 4 Gy of breast cancer patients and healthy individuals. (Dark blue 























Fig. 2. Radiation-induced MN values of breast cancer patients grouped according to receptor status. 
(*Significantly different from the receptor-negative group.)
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185 MN/1 000 BN cells (2 Gy), 518 MN/1 000  BN cells (4 Gy); 
ER-negative 159 MN/1 000 BN cells (2 Gy), 468 MN/1 000 BN cells 
(4 Gy)) (p=0.0031 and p=0.044, respectively).
Discussion
This study investigated whether SA breast cancer patients are more 
sensitive than healthy individuals to DNA damage caused by ionising 
radiation. Since differences in breast tumour characteristics are 
noted between ethnic populations, we also evaluated the possible 
differences of chromosomal radiosensitivity in the four SA ethnic 
groups.
Higher spontaneous mean MN frequencies, which were seen in 
breast cancer patients in this study, have been linked with higher 
levels of genetic instability. These significantly higher mean MN 
values occurred mainly in the white and black patients, who had 
significantly higher MN values than controls of the same ethnicity. 
The higher ages of the cancer patients, which is a limitation in our 
study, could have played a role in the elevated spontaneous MN 
values; Thierens et al.[11] have suggested an increase of 0.58 MN/
year. The higher levels of spontaneous MN in the breast cancer 
patients could also suggest higher chromosomal instability, which is 
associated with an increased risk of cancer.
The higher chromosomal radiosensitivity observed in the whole 
group of SA breast cancer patients and in the white patients in 
this study is in agreement with several international studies. It is 
interesting that the significantly higher MN values were also seen 
in black breast cancer patients, who have never been studied for 
chromosomal radiosensitivity with the micronucleus assay. This 
trend is in contrast with a study performed by Wang et al.,[12] who 
looked at chromatid breaks in young breast cancer patients and 
noted significantly higher chromatid breaks in white American breast 
cancer patients than white controls, but not in African-American 
breast cancer patients compared with black controls.
The MN values of the coloured patients and controls were not 
significantly different, although higher MN values were observed in 
the patients. However, the small sample size of this subgroup limits 
conclusions. The other small subgroups were the Indian patients and 
controls, between whom no differences in mean MN values were 
found.
Black African breast cancer patients are known to have more 
aggressive tumour phenotypes than white women, and a higher 
prevalence of triple-negative and premenopausal breast cancers.[8,9] 
These differences were not reflected in differences in chromosomal 
radiosensitivity of white and black breast cancer patients in our 
study. We found no correlation between the MN values and most 
of the clinical parameters investigated, which is in agreement with 
Baeyens et al.[13] There was an effect of ER status on MN values, with 
ER-positive women having significantly higher MN values. A similar 
trend was observed in the study of Riches et al.,[14] where patients with 
increased G2 radiosensitivity had a higher proportion of ER-positive 
tumours. The underlying reason for the higher radiation-induced 
MN in this type of breast cancer is unknown, but it could be based 
on interactions between the double-strand break repair kinase 
DNA-PK and ERs.[15] The link between ERs and MN could suggest 
a prognostic value of the micronucleus assay for ER-positive breast 
cancers. Black and coloured women with breast cancer have a higher 
incidence of ER-negative cancers,[8,9] which could have led to lower 
MN values in these groups. However, we did not observe this in our 
study. Enlarging the sample sizes and subgrouping the cancer patients 
into ethnic groups and into ER-positive and negative patients could 
provide greater insight.
Conclusion
Our results showed that SA breast cancer patients have elevated 
chromosomal radiosensitivity compared with healthy controls. The 
presence of ER positivity also influenced this radiosensitivity. More 
rigorous extended studies on the different ethnic groups are needed 
to validate our findings and to unravel the underlying mechanisms.
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